Showing posts with label Macmillan. Show all posts
Showing posts with label Macmillan. Show all posts

Friday, 2 March 2018

Sugar and Cancer: sweet surrender? Taking the lid off the sugar controversy - by Robin Daly

This week's blog post is written by our founder, Robin Daly. He discusses the controversial topic of sugar and cancer...


In cancer, you don’t have to look too far to find divided opinions on most aspects of theory, causation, diagnosis, treatment and more, but few are more polarised or more hotly debated than the role - or maybe irrelevance - of dietary sugar.

Here’s what the two largest cancer charities in the UK have to say on the subject:

At No 4 in Cancer Research UK’s Top 10 Persistent Myths Debunked is ‘Cancer has a sweet tooth’.[1]

And Macmillan state confidently that ‘Sugar in your diet doesn't directly increase the risk of cancer, or encourage it to grow.’[2]

At the other end of the spectrum we have views such as Dr Mark Hyman’s. Hyman is the leading voice in the Functional Medicine movement that is now gaining significant traction in the US.

‘The number one thing you can do to prevent or control cancer is to control insulin levels with a high-fiber diet rich in real, fresh, whole foods and minimize or eliminate sugary, processed, insulin-raising foods.’[3]

And top oncologist and advocate of Lifestyle Medicine Professor Robert Thomas wraps up an extensive review of all the science demonstrating a link between refined sugars and carbohydrates and cancer by saying:

‘In conclusion, although much of the evidence for the cancer promoting risks of sugar and high GI carbohydrate is from laboratory or large cohort trials, considering all the studies together its link to cancer is becoming increasingly convincing. Instead of the pro-sugar camp claiming that more trials are needed to prove the link, perhaps a more sensible approach is to assume there is a link, unless proven otherwise, as certainly no study to date has ever suggested sugar is healthy, and the problem is getting worse.[4]

Where did it all start?

Back in the 1920s, Nobel prize-winning German scientist Otto Warburg discovered that one of the distinctive features of cancer cells is that they have damaged mitochondria. Mitochondria are the cells’ energy generators, and the damage means that cancer cells turn away from oxygen as an energy source and instead use fermentation. Fermentation is an inefficient process that doesn’t require oxygen, but that does need large quantities of glucose. This led Warburg to hypothesise that damaged mitochondria are the source of cancer, and that this provides a universal way of targeting cancers, by starving them of the steady supply of glucose they require.

This view of cancer as a ‘metabolic’ issue, was surpassed during the twentieth century by the somatic mutation theory, which lays the blame firmly on genetic defects. Although the gene theory has substantially failed to deliver on the targeted cures that were at one time considered a future certainty, the division between the two theories - in which both see each other as preoccupied with a side effect - lives on. It’s a testament to the power of marketing that, despite giving so little bang for the immense number of bucks invested, gene theory remains predominant, and sugar remains a facet of outdated metabolic theory.

The cautionary principle

Prof Thomas makes the point that, given the sheer volume of good evidence pointing towards dietary refined sugars and carbohydrates as both a source and driver of cancer, along with the catastrophic way that the grim reaper, cancer, is scything its way through developed nations around the globe, a zero-cost, safe intervention such as reducing intake of refined foods should be seen as eminently worth trying. Making utterly confident pronouncements about the absence of a relationship between sugar and cancer depends entirely on a totally suspect system that seeks to portray evidence as a binary ‘evidence/no evidence’ scenario, rather than as a more nuanced sliding scale of ‘more evidence’, ‘better evidence’.

All down the centuries, scientists have sought to equate scientific understanding with absolute certainty. Given the repeated experience of just how wrong science can be, a degree of uncertainty and even humility would, at this point, be both pragmatic and realistic. It’s well past time that scientists ditched the permanent ‘they used to think they knew, but now we know’ stance, for good. Clinging to increasingly untenable certainties is not just foolish, in public health it wreaks hell with people’s lives. The most obvious recent example of this is the ‘low fat’ myth that held sway for half a century and even now is a continuing mantra of organisations which have yet to find a way to reverse their position without completely losing face.[5] Corporations are often nimbler than governments or charities when it comes to seeing the writing on the wall; protecting their bottom line is always a higher priority than sticking to dogma. Unilever, who have recently struck out in a new direction by buying Pukka, have sold off their margarine interests - which it describes as a ‘declining sector’ -  including major brands such as Flora and Bertolli.[6]

Fuel for the feud

It’s also important not to overlook the role of business in perpetuating scientific ‘certainties’. Once a story takes hold - such as ‘fat is bad’ - the wheels of industry gear up and soon there is an avalanche of food products and medicines riding on it, generating huge profits, and a determination to keep everyone ‘on message’ for the marketing plan, whatever that may take. And so industry starts buying the science it wants, buying the scientists who are prepared to deliver the sales lines, and in no time ‘fat is bad’ is a religion with devotees around the globe. By this time, the resistance to a change of direction is, unsurprisingly, overwhelming.

The soil not the seed

The growing science of epigenetics is making it increasingly clear that just as we are deeply connected with and affected by our environment, our cells are intrinsically linked to and dependent on the microenvironment of the body. Mina Bissell, former Head of Life Sciences at Lawrence Berkeley Laboratory in California, performed a breakthrough experiment in which she demonstrated that a cancerous cell, when placed within a healthy extracellular environment, reverts to a normal healthy cell. And conversely, a healthy cell transplanted into a cancerous environment quickly becomes cancerous.[7]

This understanding is starting to creep into the mainstream. Best-selling author and oncologist Siddhartha Mukherjee writes at length in the New Yorker, giving examples from nature of species that, in their native environment, are in step with everything around them; but move them elsewhere and they can quickly become a destructive menace.[8]

Both Bissell and Muckerjee are giving indications that cancer is more about the health of the body than the state of a few genes, and absolutely no-one is currently arguing that refined sugars and carbs are good for your health.

Common sense

 So here’s a picture:

        Refined sugars and carbs are bad for our health
        In tandem with other lifestyle issues, they drive the body towards inflammation and encourage a cellular environment conducive to fermentation
        Fermentation is the the method of choice for cancer cells to get their energy

Common sense conclusion: refined sugar is a bad idea if you want to remain cancer free, and it’s a bad idea if you have cancer, as you are supporting its preferred environment. In fact Mina Bissell has gone on to demonstrate in the lab that this is indeed the case - sugar promotes the inception of cancer and fuels it once the process is under way.[9] [10]

Big messages

Public health messages seem, on the face of it, to be a good idea. But when they are conceived within an environment fuelled by business interests[11] and in which scientists are clinging to certainties well past their ‘sell-by’ date, they can go horribly, horribly wrong. The results can be far worse than if the public had been left to their own devices. Millions of people, thinking they are making healthy choices, are being utterly misled. Big, simplistic messages are the supertankers of public health: nigh-on impossible to turn around.

Sugar and cancer is one such supertanker. You can already read the first attempts to ‘manage’ the turnaround, as the rhetoric inches away from ‘sugar definitely has nothing to do with cancer whatsoever’ towards ‘it’s complicated’. Meanwhile, a recent Daily Mail headline blares out in a singularly uncomplicated manner: ‘Revealed: How sugar feeds cancer and makes it harder to treat’.[12] We are told the conclusion from a 9 year ‘breakthrough’ study (audible yawns from the Integrative and Functional Medicine camps) that ‘This link between sugar and cancer has sweeping consequences’.

What price for being ‘right’?

So far it has taken almost a century for one simple, but vital piece of information to make its way into the mainstream…. and it’s far from there yet. Cancer patients in leading hospitals across the land are still being exhorted to eat high-calorie junk food in order to keep their strength and weight up. This dogmatism looks set to kick the twenty-year refusal by doctors to wash their hands between procedures into absolute insignificance, in terms of the level of human suffering generated.

Eventually the science will force change, but of course, in reality, the science changes nothing. If it’s true that excess dietary sugar both causes and feeds cancer, then it is just as true right now, before sufficient science arrives to bludgeon the nay-sayers into submission. The effects on the lives of those with cancer is real and it is happening today on the cancer wards. If the cautionary principle were always to the fore - as of course it should always be when dealing with people’s lives - then avoiding sugar, along with many other simple precautions, would be routine, until such time as proved safe. And had this been the case, who knows, the Daily Mail might just have been able to announce the same ‘breakthrough’ a whole lot sooner - possibly even half a century or more sooner.




[1] http://scienceblog.cancerresearchuk.org/2017/05/15/sugar-and-cancer-what-you-need-to-know/
[2] https://www.macmillan.org.uk/information-and-support/coping/maintaining-a-healthy-lifestyle/healthy-eating/commonly-asked-questions-about-diet.html
[3] http://drhyman.com/blog/2015/08/07/5-strategies-to-prevent-and-treat-cancer/
[4] https://www.canceractive.com/cancer-active-page-link.aspx?n=3892&title=Sugar-intake-and-cancer-The-emerging-evidence-reviewed
[5] http://doctoraseem.com/the-truth-about-fat-and-sugar/
[6] http://www.bbc.co.uk/news/business-42365300
[7] https://www.ted.com/talks/mina_bissell_experiments_that_point_to_a_new_understanding_of_cancer
[8] https://www.newyorker.com/magazine/2017/09/11/cancers-invasion-equation
[9] https://www.jci.org/articles/view/63146
[10] http://healthinsightuk.org/2015/01/21/cancer-and-genes-have-we-got-it-badly-wrong/
[11] https://www.wsws.org/en/articles/2017/11/28/suga-n28.html
[12] http://www.dailymail.co.uk/health/article-4986706/How-sugar-feeds-cancer-makes-harder-treat.html#ixzz57ZlB1Hx9

Wednesday, 21 January 2015

Yes to Life Responds to the Latest Macmillan Report

Today's post is from our chairman, Robin Daly, in response to the recent Macmillan report which revealed that there are now a record 2.5 million people living with cancer in the UK.


At Yes to Life, we welcome the ‘real world’ report put out by Macmillan this month. Amidst all the ‘good news’ stories that ‘more people are surviving cancer than ever’, this report hits the nail on the head when it comes to focussing on the grim reality behind the latest cancer statistics. The report talks about ‘a cancer crisis of unmanageable proportions’, and states that ‘progress is a double-edged sword’.

Yes it’s true that more people are surviving cancer, but far more importantly, many more people are getting cancer than ever. That means more people will have their lives totally uprooted by cancer, will have to face gruelling, increasingly unaffordable treatments, and then very possibly to live out their extended lives in pain, disabled, or with treatment side effects that severely erode their quality of life. Macmillan are a powerful voice of non-conformity amidst the stock hyped news of ‘progress’ that we have grown accustomed to. They clearly identify that ‘growing evidence shows that many cancer patients do not return to full health after gruelling treatments and many suffer from serious side effects of the disease.’ To this we would add ‘and of the treatment’.

Tuesday, 23 September 2014

Breast Cancer Seminar Review 2014: The Importance of Exercise

Today's post discusses the importance of exercise to cancer patients at any stage of recovery, drawing on talks given by Ted Poulter, physical activity adviser to Macmillan, and Barbara Gallani, yoga specialist, at our recent July 2014 seminar ' Breast Cancer - The Power of Choice'. If you are interested in putting some of these ideas into practice, Barbara is running a specialised yoga workshop with us on Monday 13th October, for more information and a link to buy tickets please see our events page here.

As more and more studies are showing, exercise is an entirely natural and harm-free way to effectively support cancer treatment and recovery. At our major annual seminar we were fortunate to hear from two experts, Ted Poulter and Barbara Gallani, who offered practical advice on how to go about improving health with physical activity.

Ted is a senior adviser for Macmillan and having been through cancer treatment himself, offered a very personal understanding and overview of the importance of physical activity for recovery. Ted began by admitting it was a lot easier to preach than to practice but by the end of his talk it was clear that this was an effort worth making. Studies by the ACSM (American College of Sports Medicine) shows that exercise has no adverse effects and can improve health in many areas including aerobic capacity, muscular strength, reducing fatigue, slowing disease progression and contributing to protection from recurrence. Benefits have been studied in breast, colorectal, prostate and haematological cancer (which account for 50% of cancers in the UK) and particularly in breast cancer.